Simultaneous breakdown of multiple antibiotic resistance mechanisms in S. aureus

FASEB Journal

Volumn 27, Issue 12, 2013, Pages 4834-4843

  Kaneti, Galoz ^a   Sarig, Hadar ^a   Marjieh, Ibrahim ^a   Fadia, Zaknoon ^a   Mor, Amram ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Host defense peptides; Membrane potential; OAK; Oxacillin; Peptidomimetics; Synergy

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; OLIGOACYLLYSINE; OXACILLIN; PENICILLIN BINDING PROTEIN 2A; PENICILLIN G; PIPERACILLIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL STRAIN; CHEMOSENSITIZATION; CONTROLLED STUDY; CYTOPLASM; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PERITONITIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

HOST DEFENSE PEPTIDES; MEMBRANE POTENTIAL; OAK; OXACILLIN; PEPTIDOMIMETICS; SYNERGY;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; MALE; MICE; MICE, INBRED ICR; OLIGOPEPTIDES; OXACILLIN; PENICILLIN-BINDING PROTEINS; PERITONITIS; R FACTORS; SEPSIS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; TRANSCRIPTION, GENETIC;

EID: 84890500903     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-237610     Document Type: Article

References (53)

1. Mayer, M. L., Easton D. M., Hancock R. E. W. (2010) Fine tuning host responses in the face of infection: emerging roles and clinical applications of host defence peptides. In: Antimicrobial Peptides: Discovery, Design and Novel Therapeutic Strategies, 1st Ed. (Wang, G., ed) pp 195-211, Cabi, Cambridge, MA, USA
2. Szweda, P., Schielmann, M., Kotlowski, R., Gorczyca, G., Zalewska, M., and Milewski, S. (2012) Peptidoglycan hydrolasespotential weapons against Staphylococcus aureus. Appl. Microbiol. Biotechnol. 96, 1157-1174
3. Jenkins, R. E., and Cooper, R. (2012) Synergy between oxacillin and manuka honey sensitizes methicillin-resistant Staphylococcus aureus to oxacillin. J. Antimicrob. Chemother. 67, 1405-1407
4. Radzishevsky, I. S., Kovachi, T., Porat, Y., Ziserman, L., Zaknoon, F., Danino, D., and Mor, A. (2008) Structure-Activity relationships of antibacterial acyl-lysine oligomers. Chem. Biol. 15, 354-362
5. Chambers, H. F., and Deleo, F. R. (2009) Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7, 629-641
6. Kobayashi, S. D., and DeLeo, F. R. (2011) A MRSA-terious enemy among us: boosting MRSA vaccines. Nat. Med. 17, 168-169
7. Mor, A. (2010) Chemical mimics with systemic efficacy. In: Antimicrobial Peptides: Discovery, Design and Novel Therapeutic Strategies, 1st Ed. (Wang, G., ed) pp. 100-115, Cabi, Cambridge, MA, USA
8. Rotem, S., and Mor, A. (2009) Antimicrobial peptide mimics for improved therapeutic properties, Biochim. Biophys. Acta 1788, 1582-1592
9. Rotem, S., Radzishevsky, I. S., Bourdetsky, D., Navon-Venezia, S., Carmeli, Y., and Mor, A. (2008) Analogous oligo-Acyl-lysines with distinct antibacterial mechanisms. FASEB J. 22, 2652-2661
10. Makobongo, M. O., Gancz, H., Carpenter, B. M., McDaniel, D. P., and Merrell, D. S. (2012) The oligo-Acyl lysyl antimicrobial peptide C12K-2-12 exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori. Antimicrob. Agents Chemother. 56, 378-390
11. Zaknoon, F., Wein, S., Krugliak, M., Meir, O., Rotem, S., Ginsburg, H., Vial, H., and Mor, A. (2011) Antiplasmodial properties of acyl-lysyl oligomers in culture and animal models of malaria. Antimicrob. Agents Chemother. 55, 3803-3811
12. Held-Kuznetsov, V., Rotem, S., Assaraf, Y. G., and Mor, A. (2009) Host-defense peptide mimicry for novel antitumor agents. FASEB J. 23, 4299-4307
13. Epand, R. F., Sarig, H., Mor, A., and Epand, R. M. (2009) Cell-wall interactions and the selective bacteriostatic activity of a miniature oligo-Acyl-lysyl. Biophys. J. 97, 2250-2257
14. Sarig, H., Livne, L., Held-Kuznetsov, V., Zaknoon, F., Ivankin, A., Gidalevitz, D., and Mor, A. (2010) A miniature mimic of host defense peptides with systemic antibacterial efficacy. FASEB J. 24, 1904-1913
15. Sarig, H., Goldfeder, Y., Rotem, S., and Mor, A. (2011) Mechanisms mediating bactericidal properties and conditions that enhance the potency of a broad-spectrum oligo-Acyl-lysyl. Antimicrob. Agents Chemother. 55, 688-695
16. Zaknoon, F., Goldberg, K., Sarig, H., Epand, R. F., Epand, R. M., and Mor, A. (2012) Antibacterial properties of an oligo-Acyl-lysyl hexamer targeting gram-negative species. Antimicrob. Agents Chemother. 56, 4827-4832
17. Livne, L., Epand, R. F., Papahadjopoulos-Sternberg, B., Epand, R. M., and Mor, A. (2010) OAK-based cochleates as a novel approach to overcome multidrug resistance in bacteria. FASEB J. 24, 5092-5101
18. Sarig, H., Ohana, D., Epand, R. F., Mor, A., and Epand, R. M. (2011) Functional studies of cochleate assemblies of an oligoacyl-lysyl with lipid mixtures for combating bacterial multidrug resistance. FASEB J. 25, 3336-3343
19. Goldberg, K., Sarig, H., Zaknoon, F., Epand, R. F., Epand, R. M., and Mor, A. (2013) Sensitization of gram-negative bacteria by targeting the membrane potential. [E-pub ahead of print] FASEB J. 27, doi:10.1096/fj.13-227942
20. Yuan, J., Chow, D. C., Huang, W., and Palzkill, T. (2011) Identification of a-lactamase inhibitory protein variant that is a potent inhibitor of Staphylococcus PC1-lactamase. J. Mol. Biol. 406, 730-744
21. Weigel, L., Clewell, D., Gill, S., Clark, N., McDougal, L., Flannagan, S., Kolonay, J., Shetty, J., Killgore, G., and Tenover, F. (2003) Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302, 1569-1571
22. Patel, D., Kosmidis, C., Seo, S. M., and Kaatz, G. W. (2010) Ethidium bromide MIC screening for enhanced efflux pump gene expression or efflux activity in Staphylococcus aureus. Antimicrob. Agents Chemother. 54, 5070-5073
23. Poole, K. (2005) Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56, 20-51
24. Fournier, B., and Philpott, D. J. (2005) Recognition of Staphylococcus aureus by the innate immune system. Clin. Microbiol. Rev. 18, 521-540
25. Klitgaard, J. K., Skov, M. N., Kallipolitis, B. H., and Kolmos, H. J. (2008) Reversal of methicillin resistance in Staphylococcus aureus by thioridazine. J. Antimicrob. Chemother. 62, 1215-1221
26. Oliveira, D. C., and de Lencastre, H. (2011) Methicillin-resistance in Staphylococcus aureus is not affected by the overexpression in trans of the mecA gene repressor: a surprising observation, PLoS One 6, e23287
27. Arede, P., Milheirico, C., de Lencastre, H., and Oliveira, D. C. (2012) The anti-repressor MecR2 promotes the proteolysis of the mecA repressor and enables optimal expression of-lactam resistance in MRSA. PLoS Pathog. 8, e1002816
28. Wilke, M. S., Hills, T. L., Zhang, H. Z., Chambers, H. F., and Strynadka, N. C. (2004) Crystal structures of the Apo and penicillin-Acylated forms of the BlaR1-lactam sensor of Staphylococcus aureus. J. Biol. Chem. 279, 47278-47287
29. O'Callaghan, C. H., Morris, A., Kirby, S. M., and Shingler, A. H. (1972) Novel method for detection of-lactamases by using a chromogenic cephalosporin substrate. Antimicrob. Agents Chemother. 1, 283-288
30. Therien, A. G., Huber, J. L., Wilson, K. E., Beaulieu, P., Caron, A., Claveau, D., Deschamps, K., Donald, R. G., Galgoci, A. M., Gallant, M., Gu, X., Kevin, N. J., Lafleur, J., Leavitt, P. S., Lebeau-Jacob, C., Lee, S. S., Lin, M. M., Michels, A. A., Ogawa, A. M., Painter, R. E., Parish, C. A., Park, Y. W., Benton-Perdomo, L., Petcu, M., Phillips, J. W., Powles, M. A., Skorey, K. I., Tam, J., Tan, C. M., Young, K., Wong, S., Waddell, S. T., and Miesel, L. (2012) Broadening the spectrum of-lactam antibiotics through inhibition of signal peptidase type I. Antimicrob. Agents Chemother. 56, 4662-4670
31. McDougal, L. K., Steward, C. D., Killgore, G. E., Chaitram, J. M., McAllister, S. K., and Tenover, F. C. (2003) Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 41, 5113-5120
32. Ejim, L., Farha, M. A., Falconer, S. B., Wildenhain, J., Coombes, B. K., Tyers, M., Brown, E. D., and Wright, G. D. (2011) Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. Nat. Chem. Biol. 7, 348-350
33. Dhand, A., Bayer, A. S., Pogliano, J., Yang, S. J., Bolaris, M., Nizet, V., Wang, G., and Sakoulas, 5G. (2011) Use of antistaphylococcal-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding. Clin. Infect. Dis. 53, 158-163
34. Garrigos, C., Murillo, O., Lora-Tamayo, J., Verdaguer, R., Tubau, F., Cabellos, C., Cabo, J., and Ariza, J. (2012) Efficacy of daptomycin-cloxacillin combination in experimental foreignbody infection due to methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 56, 3806-3811
35. Leonard, S. N. (2012) Synergy between vancomycin and nafcillin against Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model. PLoS One 7, e42103
36. Lin, G., Pankuch, G. A., Ednie, L. M., and Appelbaum, P. C. (2010) Antistaphylococcal activities of telavancin tested alone and in combination by time-kill assay. Antimicrob. Agents Chemother. 54, 2201-2205
37. Kwon, D. H., and Lu, C. D. (2007) Polyamine effects on antibiotic susceptibility in bacteria. Antimicrob. Agents Chemother. 51, 2070-2077
38. Fields, G. B., and Noble, R. L. (1990) Solid-phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 35, 161-214
39. Pietiäinen, M., François, P., Hyyryläinen, H.-L., Tangomo, M., Sass, V., Sahl, H.-G., Schrenzel, J., and Kontinen, V. (2009) Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance. BMC Genomics 10, 429
40. Ye, J., Coulouris, G., Zaretskaya, I., Cutcutache, I., Rozen, S., and Madden, T. L. (2012) Primer-BLAST: a tool to design targetspecific primers for polymerase chain reaction. BMC Bioinformatics 13, 134
41. Anthony, E. E., Jr. (1931) A note on capsule staining. Science 73, 319-320
42. Perez-Vazquez, M., Vindel, A., Marcos, C., Oteo, J., Cuevas, O., Trincado, P., Bautista, V., Grundmann, H., and Campos, J. (2009) Spread of invasive Spanish Staphylococcus aureus spa-type t067 associated with a high prevalence of the aminoglycosidemodifying enzyme gene ant(4=)-Ia and the efflux pump genes msrA/msrB. J. Antimicrob. Chemother. 63, 21-31
43. Jana, S., and Deb, J. K. (2006) Molecular understanding of aminoglycoside action and resistance. Appl. Microbiol. Biotechnol. 70, 140-150
44. Campos, M. A., Vargas, M. A., Regueiro, V., Llompart, C. M., Alberti, S., and Bengoechea, J. A. (2004) Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect. Immun. 72, 7107-7114
45. Llobet, E., Tomas, J. M., and Bengoechea, J. A. (2008) Capsule polysaccharide is a bacterial decoy for antimicrobial peptides. Microbiology 154, 3877-3886
46. Gao, W., Cameron, D. R., Davies, J. K., Kostoulias, X., Stepnell, J., Tuck, K. L., Yeaman, M. R., Peleg, A. Y., Stinear, T. P., and Howden, B. P. (2013) The RpoB H148Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus. J. Infect. Dis. 207, 929-939
47. Strahl, H., and Hamoen, L. W. (2010) Membrane potential is important for bacterial cell division. Proc. Natl. Acad. Sci. U. S. A. 107, 12281-12286
48. Stavri, M., Piddock, L. J., and Gibbons, S. (2007) Bacterial efflux pump inhibitors from natural sources. J. Antimicrob. Chemother. 59, 1247-1260
49. Nieminen, A. L., Dawson, T. L., Gores, G. J., Kawanishi, T., Herman, B., and Lemasters, J. J. (1990) Protection by acidotic pH and fructose against lethal injury to rat hepatocytes from mitochondrial inhibitors, ionophores and oxidant chemicals. Biochem. Biophys. Res. Commun. 167, 600-606
50. Bellomo, G., Fulceri, R., Albano, E., Gamberucci, A., Pompella, A., Parola, M., and Benedetti, A. (1991) Ca2-dependent and independent mitochondrial damage in hepatocellular injury. Cell Calcium 12, 335-341
51. Yang, S. J., Xiong, Y. Q., Boyle-Vavra, S., Daum, R., Jones, T., and Bayer, A. S. (2010) Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect"). Antimicrob. Agents Chemother. 54, 3161-3169
52. Rand, K. H., and Houck, H. J. (2004) Synergy of daptomycin with oxacillin and other-lactams against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 48, 2871-2875
53. Morones-Ramirez, J. R., Winkler, J. A., Spina, C. S., and Collins, J. J. (2013) Silver enhances antibiotic activity against gramnegative bacteria. Science Transl. Med 5, 190ra81